Legis Daily

Neuromyelitis Optica Spectrum Disorder Consortium Act

USA117th CongressHR-254| House 
| Updated: 2/2/2021
Barbara Lee

Barbara Lee

Democratic Representative

California

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Neuromyelitis Optica Spectrum Disorder Consortium Act This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 11, 2021
Introduced in House
Jan 11, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Referred to the Subcommittee on Health.
  • January 11, 2021
    Introduced in House


  • January 11, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 2, 2021
    Referred to the Subcommittee on Health.

Health

Cardiovascular and respiratory healthCongressional oversightDepartment of Health and Human ServicesEmergency medical services and trauma careExecutive agency funding and structureHealth programs administration and fundingHearing, speech, and vision careImmunology and vaccinationInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Neurological disordersResearch administration and funding

Neuromyelitis Optica Spectrum Disorder Consortium Act

USA117th CongressHR-254| House 
| Updated: 2/2/2021
Neuromyelitis Optica Spectrum Disorder Consortium Act This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 11, 2021
Introduced in House
Jan 11, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Referred to the Subcommittee on Health.
  • January 11, 2021
    Introduced in House


  • January 11, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 2, 2021
    Referred to the Subcommittee on Health.
Barbara Lee

Barbara Lee

Democratic Representative

California

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthCongressional oversightDepartment of Health and Human ServicesEmergency medical services and trauma careExecutive agency funding and structureHealth programs administration and fundingHearing, speech, and vision careImmunology and vaccinationInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Neurological disordersResearch administration and funding